Photo : webshot. 

August 27, 2021

Andrew Campbell 

The study, titled “Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study,” was published on August 27 in the British Medical Journal to examine the relationship between COVID-19 vaccines and the risk of thrombocytopenia and thromboembolic events in adults in England.

According to a study of COVID-19 vaccines, the AstraZeneca jab does increase the risk of blood clots and another serious condition that can cause bleeding. However, the study discovered that the risk of such problems following a coronavirus infection was still significantly higher. The team led by the University of Oxford discovered an increased risk of stroke after the Pfizer jab, but at a much lower rate than after infection.

Patient-level data for 29,121,633 people vaccinated in England between December 1, 2020 and April 24, 2021 were obtained for the study, which looked for complications up to 28 days after being jabbed or infected. Data from the Office for National Statistics on deaths, SARS-CoV-2 positive test results, and hospital admissions from the United Kingdom's health service were linked with electronic health records (NHS).

The findings highlight the critical importance of getting vaccinated to reduce the risk of clotting and bleeding. Vaccinations are undeniably beneficial to public health.